drug · small molecule
patient view →sotorasib
Marketedupdated 2mo agoby $AMGN AMGEN INC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and non-small cell lung carcinoma and 4 investigational indications.
indications
investigational
NSCLC
targets
GTPase KRas
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that